早期术后DWI评估成人型世界卫生组织2级和3级弥漫性胶质瘤切除范围的应用价值
单中心观察性队列研究纳入2015年至2020年224例经组织学确诊的WHO 2级和3级弥漫性胶质瘤手术减容患者,由2名神经放射学顾问医师独立评估术前、早期术后和随访影像,比较使用与不使用DWI序列对切除范围的估计,发现使用DWI后30%(66/222)病例的切除范围被上调,其中58%(38/66)分类为「完全」或「超最大」切除,结论认为DWI是区分残留肿瘤与边缘缺血的有用可靠辅助手段,应常规使用。
要点
- 早期术后MRI加用DWI可使30%(66/222)的WHO 2-3级弥漫性胶质瘤病例切除范围估计上调。
- 切除范围上调病例中58%(38/66)被分类为「完全」或「超最大」切除。
- DWI上调切除范围的病例随访时78%(49/63)信号异常稳定或减小。
核心结论
- DWI是早期术后MRI中区分残留肿瘤与边缘缺血的有用且可靠辅助手段,可提高评估WHO 2级和3级弥漫性胶质瘤切除范围的准确性,应在此类病例中常规使用。
研究设计与样本
- 单中心观察性队列研究,纳入2015年1月至2020年12月间经组织学确诊的WHO 2级和3级弥漫性胶质瘤并接受手术减容的患者。
- 共224例患者接受手术减容,其中2例早期术后MRI未行DWI,最终分析222例。
- 术前、早期术后和随访影像由2名神经放射学顾问医师独立评估,分别在有和无DWI序列条件下估计切除范围。
关键影像表现/征象
- 使用DWI后30%(66/222)病例的切除范围估计被上调。
- 切除范围上调的病例中58%(38/66)被分类为「完全」或「超最大」切除。
- 在因使用DWI而上调切除范围的病例中,随访时78%(49/63)信号异常稳定或减小。
- 信号异常进展的病例中64%(9/14)被认为继发于辅助放疗。
- 使用DWI上调切除范围的患者中8%(5/63)随访时信号进展归因于真实疾病进展。
诊断标准与关键数值
- 以随访影像上信号异常稳定或减小作为支持DWI上调切除范围判断的参考表现。
临床应用与阅片要点
- 在早期术后MRI评估WHO 2级和3级弥漫性胶质瘤切除范围时,应常规加用DWI序列。
- DWI有助于将残留肿瘤与手术边缘缺血区分开来,避免将边缘缺血误判为残留肿瘤而低估切除范围。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: World Health Organization (WHO) grade 2 and 3 diffuse gliomas account for approximately 5% of primary brain tumors. They are invasive and infiltrative tumors and have considerable morbidity, causing progressive neurologic deterioration. The mean survival time is <10 years from diagnosis. Surgical debulking represents first-line management. The extent of resection is associated with progression-free and overall survival. Radiologic assessment of the extent of resection is challenging. This can be underestimated on early postoperative MRI, meaning that accurate assessment may be achieved only on delayed follow-up imaging. We hypothesized that DWI may help facilitate more reliable estimates of the extent of resection on early postoperative MRI. This study aimed to assess the utility of DWI in early postoperative MRI to evaluate the extent of resection.
MATERIALS AND METHODS: A single-center observational cohort study was performed. All patients with histologically confirmed WHO grade 2 and 3 gliomas managed with surgical debulking between January 2015 and December 2020 were identified. Preoperative, early postoperative, and follow-up imaging were reviewed independently by 2 consultant neuroradiologists. The extent of resection was estimated with and without DWI sequences for each case.
RESULTS: Two hundred twenty-four patients with WHO grade 2 and 3 gliomas were managed with surgical debulking between 2015 and 2020. DWI was not performed on early postoperative MRI in 2 patients. With the use of DWI, the extent of resection was upgraded in 30% of cases (n = 66/222) and classified as "complete" or "supramaximal" in 58% of these patients (n = 38/66). In cases in which the extent of resection was upgraded with the use of DWI, signal abnormality was stable or reduced at follow-up in 78% (n = 49/63). In cases with worsening signal abnormality, 64% were deemed to be secondary to adjuvant radiation therapy (n = 9/14). Eight percent (n = 5/63) of patients with an increased estimated extent of resection using DWI demonstrated signal progression attributed to true disease progression at follow-up.
CONCLUSIONS: DWI is a helpful and reliable adjunct in differentiating residual tumor from marginal ischemia in early postoperative MRI in WHO grade 2 and 3 diffuse gliomas and increases the accuracy in assessing the extent of resection. It should be used routinely in these cases.
引用
- Brosnan C, Henry J, McHugh P, et al. Utility of Early Postoperative DWI to Assess the Extent of Resection of Adult-Type World Health Organization Grade 2 and 3 Diffuse Gliomas. AJNR Am J Neuroradiol. 2024. PMID: 39326884. doi:10.3174/ajnr.A8397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。